Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Minireview

  • Minireview
    Development of Difluoromethylornithine (DFMO) as a Chemoprevention Agent
    Frank L. Meyskens Jr. and Eugene W. Gerner
    Clin Cancer Res May 1 1999 5 (5) 945-951;

Advances in Brief

  • Advances in Brief
    Phase I Study of 90Y-labeled B72.3 Intraperitoneal Administration in Patients with Ovarian Cancer: Effect of Dose and EDTA Coadministration on Pharmacokinetics and Toxicity
    Michael G. Rosenblum, Claire F. Verschraegen, James L. Murray, Andrzej P. Kudelka, Jacalyn Gano, Lawrence Cheung and John J. Kavanagh
    Clin Cancer Res May 1 1999 5 (5) 953-961;

  • Advances in Brief
    Centrosome Abnormalities in Pancreatic Ductal Carcinoma
    Norihiro Sato, Kazuhiro Mizumoto, Masafumi Nakamura, Kenjiro Nakamura, Masahiro Kusumoto, Hideaki Niiyama, Takahiro Ogawa and Masao Tanaka
    Clin Cancer Res May 1 1999 5 (5) 963-970;

  • Advances in Brief
    Molecular Detection of Telomerase-positive Circulating Epithelial Cells in Metastatic Breast Cancer Patients
    Jean-Charles Soria, Laurent R. Gauthier, Eric Raymond, Christine Granotier, Luc Morat, Jean-Pierre Armand, François D. Boussin and Laure Sabatier
    Clin Cancer Res May 1 1999 5 (5) 971-975;

  • Advances in Brief
    Overexpression of the Cyclin-dependent Kinase Inhibitor p16 Is Associated with Tumor Recurrence in Human Prostate Cancer
    Cheryl T. Lee, Paola Capodieci, Iman Osman, Melissa Fazzari, Joseph Ferrara, Howard I. Scher and Carlos Cordon-Cardo
    Clin Cancer Res May 1 1999 5 (5) 977-983;

  • Advances in Brief
    Receptor for Interleukin 13 Is a Marker and Therapeutic Target for Human High-Grade Gliomas
    Waldemar Debinski, Denise M. Gibo, Stanley W. Hulet, James R. Connor and G. Yancey Gillespie
    Clin Cancer Res May 1 1999 5 (5) 985-990;

  • Advances in Brief
    Comparison of Features of Human Lung Cancer Cell Lines and Their Corresponding Tumors
    Ignacio I. Wistuba, David Bryant, Carmen Behrens, Sara Milchgrub, Arvind K. Virmani, Raheela Ashfaq, John D. Minna and Adi F. Gazdar
    Clin Cancer Res May 1 1999 5 (5) 991-1000;

  • Advances in Brief
    Prognostic Significance of Elevated Cyclooxygenase 2 Expression in Primary, Resected Lung Adenocarcinomas
    Hiroyuki Achiwa, Yasushi Yatabe, Toyoaki Hida, Tetsuo Kuroishi, Ken-ichi Kozaki, Shigeo Nakamura, Makoto Ogawa, Takahiko Sugiura, Tetsuya Mitsudomi and Takashi Takahashir
    Clin Cancer Res May 1 1999 5 (5) 1001-1005;

  • Advances in Brief
    Cisplatin-induced Activation of Mitogen-activated Protein Kinases in Ovarian Carcinoma Cells: Inhibition of Extracellular Signal-regulated Kinase Activity Increases Sensitivity to Cisplatin
    Diane L. Persons, Eugenia M. Yazlovitskaya, Wei Cui and Jill C. Pelling
    Clin Cancer Res May 1 1999 5 (5) 1007-1014;

  • Advances in Brief
    Recombinant Adenovirus Expressing Wild-Type p53 Is Antiangiogenic: A Proposed Mechanism for Bystander Effect
    Masahiko Nishizaki, Toshiyoshi Fujiwara, Tohru Tanida, Akio Hizuta, Hiroyuki Nishimori, Takashi Tokino, Yusuke Nakamura, Michael Bouvet, Jack A. Roth and Noriaki Tanaka
    Clin Cancer Res May 1 1999 5 (5) 1015-1023;

Clinical Trials

  • Clinical Trials
    Locoregional Regulatory Peptide Receptor Targeting with the Diffusible Somatostatin Analogue 90Y-Labeled DOTA0-d-Phe1-Tyr3-octreotide (DOTATOC): A Pilot Study in Human Gliomas
    Adrian Merlo, Oliver Hausmann, Morten Wasner, Philipp Steiner, Andreas Otte, Eduard Jermann, Peter Freitag, Jean-Claude Reubi, Jan Müller-Brand, Otmar Gratzl and Helmut R. Mäcke
    Clin Cancer Res May 1 1999 5 (5) 1025-1033;

  • Clinical Trials
    Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy
    Michael Mohr, Eva Hilgenfeld, Thomas Fietz, Berthold Hoppe, Michael Koenigsmann, Marianne Hoffmann, Wolfgang U. Knauf, Uwe Cassens, Walter Sibrowski, Joachim Kienast, Eckhard Thiel and Wolfgang E. Berdel
    Clin Cancer Res May 1 1999 5 (5) 1035-1040;

Molecular Oncology, Markers, Clinical Correlates

  • Molecular Oncology, Markers, Clinical Correlates
    Vascular Stroma Formation in Carcinoma in Situ, Invasive Carcinoma, and Metastatic Carcinoma of the Breast
    Lawrence F. Brown, Anthony J. Guidi, Stuart J. Schnitt, Livingston Van De Water, Maria Luisa Iruela-Arispe, Tet-Kin Yeo, Kathi Tognazzi and Harold F. Dvorak
    Clin Cancer Res May 1 1999 5 (5) 1041-1056;

  • Molecular Oncology, Markers, Clinical Correlates
    Paradoxical Correlations of Cyclin-dependent Kinase Inhibitors p21waf1/cip1 and p27kip1 in Metastatic Colorectal Carcinoma
    Jonathan D. heng, Bruce A. Werness, James S. Babb and Neal J. Meropol
    Clin Cancer Res May 1 1999 5 (5) 1057-1062;

  • Molecular Oncology, Markers, Clinical Correlates
    Alterations in Expression of Basic Fibroblast Growth Factor (FGF) 2 and Its Receptor FGFR-1 in Human Prostate Cancer
    Dipak Giri, Frederic Ropiquet and Michael Ittmann
    Clin Cancer Res May 1 1999 5 (5) 1063-1071;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of the Hyaluronan Receptor, CD44S, in Epithelial Ovarian Cancer Is an Independent Predictor of Survival
    Sanjiv Kayastha, Andrew N., Freedman M., Steven Piver, Jhansi Mukkamalla, Maritza Romero-Guittierez and Bruce A. Werness
    Clin Cancer Res May 1 1999 5 (5) 1073-1076;

  • Molecular Oncology, Markers, Clinical Correlates
    Estrogen Receptor Methylation Is Associated with Improved Survival in Adult Acute Myeloid Leukemia
    Qing Li, Kenneth J. Kopecky, Avinash Mohan, Cheryl L. Willman, Frederick R. Appelbaum, James K. Weick and Jean-Pierre J. Issa
    Clin Cancer Res May 1 1999 5 (5) 1077-1084;

  • Molecular Oncology, Markers, Clinical Correlates
    Disrupted p53 Function as Predictor of Treatment Failure and Poor Prognosis in B- and T-Cell Non-Hodgkin’s Lymphoma
    Michael B. Møller, Anne-Marie Gerdes, Karsten Skjødt, Leif S. Mortensen and Niels T. Pedersen
    Clin Cancer Res May 1 1999 5 (5) 1085-1091;

  • Molecular Oncology, Markers, Clinical Correlates
    Endothelial Cell Nitric Oxide Synthase in Peritumoral Microvessels Is a Favorable Prognostic Indicator in Premenopausal Breast Cancer Patients
    Kirsten Mortensen, Susanne Holck, Ib Jarle Christensen, Jan Skouv, David M. Hougaard, Jens Blom and Lars-Inge Larsson
    Clin Cancer Res May 1 1999 5 (5) 1093-1097;

  • Molecular Oncology, Markers, Clinical Correlates
    Detection of Melanoma Cells in the Blood of Melanoma Patients by Melanoma-inhibitory Activity (MIA) Reverse Transcription-PCR
    Marcus Mühlbauer, Nicole Langenbach, Wilhelm Stolz, Ruediger Hein, M. Landthaler, Reinhard Buettner and Anja-Katrin Bosserhoff
    Clin Cancer Res May 1 1999 5 (5) 1099-1105;

  • Molecular Oncology, Markers, Clinical Correlates
    Macrophage Infiltration and Heme Oxygenase-1 Expression Correlate with Angiogenesis in Human Gliomas
    Akihiro Nishie, Mayumi Ono, Tadahisa Shono, Junichi Fukushi, Michihiro Otsubo, Hitoshi Onoue, Yushi Ito, Takanori Inamura, Kiyonobu Ikezaki, Masashi Fukui, Toru Iwaki and Michihiko Kuwano
    Clin Cancer Res May 1 1999 5 (5) 1107-1113;

  • Molecular Oncology, Markers, Clinical Correlates
    Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes
    Christian Ries, Florian Loher, Chuanbing Zang, Manfred G. Ismair and Petro E. Petrides
    Clin Cancer Res May 1 1999 5 (5) 1115-1124;

  • Molecular Oncology, Markers, Clinical Correlates
    Increased Serum Angiogenin Concentration in Colorectal Cancer Is Correlated with Cancer Progression
    Shouji Shimoyama, Kazuki Yamasaki, Masaki Kawahara and Michio Kaminishi
    Clin Cancer Res May 1 1999 5 (5) 1125-1130;

  • Molecular Oncology, Markers, Clinical Correlates
    Significance of Thymidine Phosphorylase as a Marker of Protumor Monocytes in Breast Cancer
    Masakazu Toi, Takayuki Ueno, Hiroshi Matsumoto, Hisashi Saji, Nobuaki Funata, Morio Koike and Takeshi Tominaga
    Clin Cancer Res May 1 1999 5 (5) 1131-1137;

  • Molecular Oncology, Markers, Clinical Correlates
    Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma
    Yoshio Tomizawa, Jun-ichi Adachi, Takashi Kohno, Kunihiro Hamada, Ryusei Saito, Masayuki Noguchi, Yoshihiro Matsuno, Setsuo Hirohashi, Naohito Yamaguchi and Jun Yokota
    Clin Cancer Res May 1 1999 5 (5) 1139-1146;

  • Molecular Oncology, Markers, Clinical Correlates
    Detection of Mutations of p53 Tumor Suppressor Gene in Pancreatic Juice and Its Application to Diagnosis of Patients with Pancreatic Cancer: Comparison with K-ras Mutation
    Yasushi Yamaguchi, Hiroyuki Watanabe, Songür Yrdiran, Koushirou Ohtsubo, Yoshiharu Motoo, Takasi Okai and Norio Sawabu
    Clin Cancer Res May 1 1999 5 (5) 1147-1153;

  • Molecular Oncology, Markers, Clinical Correlates
    Telomere Stability Is Frequently Impaired in High-Risk Groups of Patients with Myelodysplastic Syndromes
    Junko H. Ohyashiki, Hiroshi Iwama, Naoyuki Yahata, Keiko Ando, Shigefumi Hayashi, Jerry W. Shay and Kazuma Ohyashiki
    Clin Cancer Res May 1 1999 5 (5) 1155-1160;

Experimental Therapeutics, Preclinical Pharmacology

  • Experimental Therapeutics, Preclinical Pharmacology
    Predictive Value of Preclinical Toxicology Studies for Platinum Anticancer Drugs,
    Diana L. Clark, Paul A. Andrews, David D. Smith, Joseph J. DeGeorge, Robert L. Justice and Julie G. Beitz
    Clin Cancer Res May 1 1999 5 (5) 1161-1167;

  • Experimental Therapeutics, Preclinical Pharmacology
    An Improved Nonisotopic Test to Screen a Large Series of New Inhibitor Molecules of Poly(ADP-ribose) Polymerase Activity for Therapeutic Applications
    Patrice Decker, Everson Alves Miranda, Gilbert de Murcia and Sylviane Muller
    Clin Cancer Res May 1 1999 5 (5) 1169-1172;

  • Experimental Therapeutics, Preclinical Pharmacology
    Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination
    Nathalie Maitre, Jason M. Brown, Marina Demcheva, Joseph R. Kelley, Mark A. Lockett, John Vournakis and David J. Cole
    Clin Cancer Res May 1 1999 5 (5) 1173-1182;

  • Experimental Therapeutics, Preclinical Pharmacology
    Treatment of Neoplastic Meningitis with Intrathecal Temozolomide
    John H. Sampson, Gary E. Archer, Alan T. Villavicencio, Roger E. McLendon, Allan H. Friedman, W. Robert Bishop, Darell D. Bigner and Henry S. Friedman
    Clin Cancer Res May 1 1999 5 (5) 1183-1188;

  • Experimental Therapeutics, Preclinical Pharmacology
    Cellular Pharmacology of the Combination of the DNA Topoisomerase I Inhibitor SN-38 and the Diaminocyclohexane Platinum Derivative Oxaliplatin
    Nadia Zeghari-Squalli, Eric Raymond, Esteban Cvitkovic and François Goldwasser
    Clin Cancer Res May 1 1999 5 (5) 1189-1196;

Cancer Biology, Immunology, Cytokines

  • Cancer Biology, Immunology, Cytokines
    Activation of Nuclear Factor-κB in Human Metastatic Melanoma Cells and the Effect of Oxidative Stress
    Frank L. Meyskens Jr., Julie A. Buckmeier, Susan E. McNulty and Niloufar B. Tohidian
    Clin Cancer Res May 1 1999 5 (5) 1197-1202;

  • Cancer Biology, Immunology, Cytokines
    Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1β, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells
    Yasuo Saijo, Xin Hong, Masashi Tanaka, Ryushi Tazawa, Shu Qin Liu, Kaoru Saijo, Tadao Ohno, Kaoru Koike, Kazuhiro Ohkuda, Ken Satoh and Toshihiro Nukiwa
    Clin Cancer Res May 1 1999 5 (5) 1203-1209;

  • Cancer Biology, Immunology, Cytokines
    Suppression of Telomerase, Reexpression of KAI1, and Abrogation of Tumorigenicity by Nerve Growth Factor in Prostate Cancer Cell Lines
    Sandra Sigala, Isabella Faraoni, Daniela Botticini, Marcelo Paez-Pereda, Cristina Missale, Enzo Bonmassar and PierFranco Spano
    Clin Cancer Res May 1 1999 5 (5) 1211-1218;

  • Cancer Biology, Immunology, Cytokines
    Mechanisms of Apoptosis in T Cells from Patients with Renal Cell Carcinoma
    Robert G. Uzzo, Patricia Rayman, Vladimir Kolenko, Peter E. Clark, Tracy Bloom, A. Michelle Ward, Luis Molto, Charles Tannenbaum, Lydia J. Worford, Ronald Bukowski, Raymond Tubbs, Eric D. Hsi, Neil H. Bander, Andrew C. Novick and James H. Finke
    Clin Cancer Res May 1 1999 5 (5) 1219-1229;

  • Cancer Biology, Immunology, Cytokines
    Loss of Heterozygosity of the Rb Gene Correlates with pRb Protein Expression and Associates with p53 Alteration in Human Esophageal Cancer
    Eric Poe Xing, Guang-Yu Yang, Li-Dong Wang, Stephanie Tao Shi and Chung S. Yang
    Clin Cancer Res May 1 1999 5 (5) 1231-1240;

Back to top
PreviousNext
May 1999
Volume 5, Issue 5
  • Table of Contents

Sign up for alerts

Jump to

  • Minireview
  • Advances in Brief
  • Clinical Trials
  • Molecular Oncology, Markers, Clinical Correlates
  • Experimental Therapeutics, Preclinical Pharmacology
  • Cancer Biology, Immunology, Cytokines
Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement